1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Characterisation of heritable TP53-related cancer syndrome in Sweden—a nationwide study of genotype-phenotype correlations in 90 families
(2025) In European Journal of Human Genetics
- Contribution to journal › Article
- 2024
-
Mark
Public attitudes challenge clinical practice on genetic risk disclosure in favour of healthcare-provided direct dissemination to relatives
Rosén, Anna ; Krajc, Mateja ; Ehrencrona, Hans LU
and Bajalica-Lagercrantz, Svetlana
(2024)
In European Journal of Human Genetics
32(1).
p.6-7
- Contribution to journal › Debate/Note/Editorial
-
Mark
Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors—a nationwide, prospective Swedish study
- Contribution to journal › Article
- 2023
-
Mark
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
- Contribution to journal › Article
-
Mark
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer
- Contribution to journal › Article
- 2022
-
Mark
Whole-Body MRI Surveillance—Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53)
- Contribution to journal › Article
-
Mark
Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies
Hägerbrand, Karin LU ; Varas, Laura LU ; Deronic, Adnan LU ; Nyesiga, Barnabas ; Sundstedt, Anette LU ; Ljung, Lill ; Sakellariou, Christina LU
; Werchau, Doreen
; Thagesson, Mia
and Gomez Jimenez, David
LU
, et al.
(2022)
In Journal for ImmunoTherapy of Cancer
10(11).
- Contribution to journal › Article
- 2020
-
Mark
Public support for healthcare-mediated disclosure of hereditary cancer risk information : Results from a population-based survey in Sweden
Andersson, Andreas ; Hawranek, Carolina ; Öfverholm, Anna ; Ehrencrona, Hans LU
; Grill, Kalle
; Hajdarevic, Senada
; Melin, Beatrice
; Tham, Emma
; Hellquist, Barbro Numan
and Rosén, Anna
(2020)
In Hereditary Cancer in Clinical Practice
18(1).
- Contribution to journal › Article
- 2019
-
Mark
The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
- Contribution to journal › Article
- 2018
-
Mark
Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression
- Contribution to journal › Article